Nuevogenix

Current Vaccine Technology

Overview of Modern Vaccine Platforms

Nuevogenix leverages advanced vaccine technologies to design highly effective and safe vaccines. Current approaches include inactivated vaccines, recombinant protein vaccines, viral vector vaccines, mRNA vaccines, and DNA vaccines each tailored to optimize immune response and disease prevention in livestock.

Key Vaccine Technologies

Recombinant Protein Vaccines

Produce targeted antigens using recombinant DNA technology for precise immune responses.

Inactivated Vaccines

Utilize killed pathogens to safely stimulate immunity without risk of infection.

Viral Vector Vaccines

Deliver antigens via engineered viral vectors to elicit robust and long-lasting immunity.

mRNA Vaccines

Leverage messenger RNA to instruct cells to produce antigens, offering rapid and flexible vaccine development.

DNA Vaccines

Introduce DNA encoding antigens directly to cells, inducing immunity through the host's cellular machinery.

Live Attenuated Vaccine

Introduce DNA encoding antigens directly to cells, inducing immunity through the host's cellular machinery.

Virus-Like-Particles-Vaccine

Leverage messenger RNA to instruct cells to produce antigens, offering rapid and flexible vaccine development.

Benefits of Modern Vaccines

By applying these advanced technologies, Nuevogenix ensures vaccines that are:

Partner with Nuevogenix Today

Discover how our advanced vaccine technologies can safeguard your livestock and
drive sustainable animal health solutions.